p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia

被引:95
作者
Kong, Christina S. [1 ]
Balzer, Bonnie L. [1 ]
Troxell, Megan L. [1 ]
Patterson, Bruce K. [1 ]
Longacre, Teri A. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA
关键词
human papilloma virus; in situ hybridization; p16(INK4A); squamous intraepithelial lesion; atypical squamous metaplasia;
D O I
10.1097/01.pas.0000213347.65014.ee
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In situ hybridization (ISH) assays for high-risk human papillomavirus (HR-HPV) and irnmunohistochemical (IHC) assays for surrogate markers such as p16(INK4A) can be useful in detecting HR-HPV in cervical dysplasia, but the use of these markers in problematic cervical biopsies has not been well-established. We evaluated 3 chromogenic ISH assays (Ventana INFORM HPVII and HPVIII and DakoCytomation GenPoint) in conjunction with p16 (INK4A) IHC and HPV polymerase chain reaction in a study set consisting of 12 low-grade squamous intraepithelial lesions, 16 high-grade squamous intraepithelial lesions, and 30 benign cervix samples. A test set of 28 cases of 9 atypical squamous metaplasia were also evaluated with Ventana HPVIII ISH and p 16(INK4A) IHC. In the study set, the sensitivity of the DakoCytomation ISH assay (which detects HPV subtypes 16, 18, 31, 33, 35, 397 45, 52, 56, 58, 59, and 68) was similar to the Ventana HPVII assay but less than that of the Ventana HPVIII ISH assay (both of which detect HPV subtypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 66) and less than p16(INK4A) IHC (55.6% vs. 53.6 vs. 69.2% vs. 82. 1 %). All HPV ISH assays exhibited 100% specificity. p16(INK4A) reactivity consisted of 2 patterns: focal strong and diffuse strong. Because focal strong p16(INK4A) reactivity was identified in benign squamous epithelium (6.7% cases) and dysplastic epithelium, it was considered an equivocal result and only diffuse strong reactivity was considered to be specific for the presence of HR-HPV. In the squamous intraepithelial lesions study set, the difference in sensitivity between Ventana HPVIII ISH and p16(INK4A) was not statistically significant. However, in the atypical squamous metaplasia test set cases, p16(INK4A) reactivity (focal strong and diffuse strong) was significantly more sensitive than Ventana HPVIII ISH in correlating with the presence of human papillomavirus as detected by polymerase chain reaction (83.3% vs. 33.3% P = 0.004). Because focal strong p16(INK4A) reactivity is less specific, cases with this staining pattern are considered atypical and require further evaluation by other means. Overall, p 16(INK4A) IHC is considered the best candidate for the initial assessment of cervical biopsies that are histologically indeterminate for dysplasia given its wide availability, comparative case of interpretation, and high sensitivity and specificity.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 35 条
[11]  
Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940
[12]  
Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt
[13]  
221::AID-IJC11&gt
[14]  
3.0.CO
[15]  
2-2
[16]   P16INK4A immunoexpression and HPV in situ hybridization signal patterns -: Potential markers of high-grade cervical intraepithelial neoplasia [J].
Kalof, AN ;
Evans, MF ;
Simmons-Arnold, L ;
Beatty, BG ;
Cooper, K .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (05) :674-679
[17]   Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia [J].
Keating, JT ;
Cviko, A ;
Riethdorf, S ;
Riethdorf, L ;
Quade, BJ ;
Sun, DQ ;
Duensing, S ;
Sheets, EE ;
Munger, K ;
Crum, CP .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (07) :884-891
[18]   Overexpression of p16ink4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri [J].
Klaes, R ;
Friedrich, T ;
Spitkovsky, D ;
Ridder, R ;
Rudy, W ;
Petry, U ;
Dallenbach-Hellweg, G ;
Schmidt, D ;
Doeberitz, MV .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (02) :276-284
[19]  
Kong CS, 2005, MODERN PATHOL, V18, p189A
[20]  
Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397